Connect with us

Health

Clinical trial completion rates decline during COVID-19 pandemic – Science Daily

Social distancing and lockdowns may have affected clinical researchers’ ability to finish trials, researchers report. Study completion rates dropped worldwide between…

Published

on

Article feature image

Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted the…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Study discusses impact of chemotherapy on immune cells – Hindustan Times
Article feature image
I’m One Of The Few Young Aussies Who Had The AstraZeneca COVID-19 Vaccine. Here’s What Happened. – MTV News Australia